Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Research

• Publication date

  2005-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-04-3885PMID 15994977PMCID PMC1364476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Double Dissociation of Hangul and Hanja Reading in Korean Patients with Stroke

  2006cited by this paper
• Genetic variation in the progesterone receptor gene and ovarian cancer risk.

  2005cited by this paper
• Subfertility and defective folliculogenesis in female mice lacking androgen receptor.

  2004influential reference
• Structural and functional consequences of glutamine tract variation in the androgen receptor.

  2004influential reference
• The CAG repeats in exon 1 of the androgen receptor gene are significantly longer in endometrial cancer patients.

  2003influential reference
• Choosing Haplotype-Tagging SNPS Based on Unphased Genotype Data Using a Preliminary Sample of Unrelated Subjects with an Example from the Multiethnic Cohort Study

  2003cited by this paper
• Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.

  2003influential reference
• Generation and characterization of androgen receptor knockout (ARKO) mice: An in vivo model for the study of androgen functions in selective tissues

  2002influential reference
• Testing Association of Statistically Inferred Haplotypes with Discrete and Continuous Traits in Samples of Unrelated Individuals

  2002cited by this paper
• The human ovarian surface epithelium is an androgen responsive tissue

  2002cited by this paper
• The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.

  2002influential reference
• Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype

  2002influential reference
• Haplotype block structure and its applications to association studies: power and study designs.

  2002cited by this paper
• The Structure of Haplotype Blocks in the Human Genome

  2002cited by this paper
• Androgen receptor CAG repeats and prostate cancer.

  2002influential reference
• Polymorphic CAG repeat length within the androgen receptor gene: identification of a subgroup of patients with increased risk of ovarian cancer.

  2002influential reference
• The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series.

  2001cited by this paper
• Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer.

  2001influential reference
• CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers

  2001cited by this paper
• The polymorphic CAG repeat of the androgen receptor gene: a potential role in breast cancer in women over 40

  2001cited by this paper
• The polymorphic CAG repeat in the androgen receptor gene in Jewish Israeli women with endometrial carcinoma

  2001cited by this paper
• Androgen receptor gene CAG trinucleotide repeats in anovulatory infertility and polycystic ovaries.

  2000influential reference
• Androgen receptor exon 1 cag repeat length and risk of ovarian cancer

  2000influential reference
• Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length.

  2000cited by this paper
• Oestrogen, progesterone, and androgen receptors in ovarian neoplasia: correlation between immunohistochemical and biochemical receptor analyses

  2000influential reference
• Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells.

  1999cited by this paper
• Expression of human estrogen receptor-α and -β, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells

  1999cited by this paper
• No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer.

  1999influential reference
• Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer.

  1999cited by this paper
• The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia.

  1999cited by this paper
• Over-the-counter analgesics and risk of ovarian cancer.

  1998influential reference
• Frame-shift mutation in hormone binding domain of human androgen receptor gene causes complete androgen insensitivity.

  1998cited by this paper
• The induction of benign epithelial neoplasms of the ovaries of guinea pigs by testosterone stimulation: a potential animal model.

  1997cited by this paper
• Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility.

  1997cited by this paper
• A phase II study of flutamide in ovarian cancer.

  1997cited by this paper
• Physical Activity, Waist‐to-Hip Ratio, and Other Risk Factors for Ovarian Cancer: A Follow‐up Study of Older Women

  1996cited by this paper
• Epithelial Ovarian Cancer Risk Among Women With Polycystic Ovary Syndrome

  1996cited by this paper
• The Future of Genetic Studies of Complex Human Diseases

  1996cited by this paper
• Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies.

  1995cited by this paper
• Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population.

  1995cited by this paper
• Serum gonadotropins and steroid hormones and the development of ovarian cancer.

  1995cited by this paper
• Leu‐676‐Pro mutation of the androgen receptor causes complete androgen insensitivity syndrome in a large Hutterite kindred

  1995cited by this paper
• Phase II trial of flutamide in advanced ovarian cancer: an EORTC Gynaecological Cancer Cooperative Group study.

  1994cited by this paper
• Size Polymorphisms of the Androgen Receptor Among Female Hispanics and Correlation With Androgenic Characteristics

  1994cited by this paper
• Re: "Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women".

  1993cited by this paper
• Aging and development of ovarian epithelial carcinoma: the relevance of changes in ovarian stromal androgen production.

  1993cited by this paper
• An immunohistochemical evaluation of androgen and progesterone receptors in ovarian tumors.

  1993cited by this paper
• Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups.

  1992cited by this paper
• Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. I. Methods. Collaborative Ovarian Cancer Group.

  1992cited by this paper
• Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group.

  1992cited by this paper
• Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy

  1991cited by this paper
• Androgen receptor predominance in human ovarian carcinoma.

  1987influential reference
• THE INTERACTION OF SELECTION AND LINKAGE. II. OPTIMUM MODELS.

  1964cited by this paper

• Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes

  2025cites this paper
• Associations between parity, history of breastfeeding, and T cell profile of ovarian tumors.

  2025cites this paper
• Emerging SERS and TERS MoS2 platforms for the characterization of plasma-derived extracellular vesicles.

  2025cites this paper
• A systematic review of the epidemiology evidence on talc and cancer

  2024cites this paper
• Impact of spatial clustering of cytotoxic and tumor infiltrating lymphocytes on overall survival in women with high grade serous ovarian cancer

  2024cites this paper
• Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis

  2023cites this paper
• A framework for assessing interactions for risk stratification models: the example of ovarian cancer.

  2023cites this paper
• Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery.

  2022cites this paper
• Effects of risk factors for ovarian cancer in women with and without endometriosis

  2022cites this paper
• Lifetime ovulatory years and ovarian cancer gene expression profiles

  2022cites this paper
• High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival

  2021cites this paper
• Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association.

  2021cites this paper
• Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins

  2021cites this paper
• Androgen/Androgen Receptor Signaling in Ovarian Cancer: Molecular Regulation and Therapeutic Potentials

  2021cites this paper
• Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer

  2020cites this paper
• Expanding our understanding of ovarian cancer risk: the role of incomplete pregnancies.

  2020cites this paper
• Association Between Breastfeeding and Ovarian Cancer Risk.

  2020cites this paper
• The Role of Androgen Receptor Signaling in Ovarian Cancer

  2019cites this paper
• Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study.

  2019cites this paper
• Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium

  2019cites this paper
• Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence

  2018cites this paper
• Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.

  2018cites this paper
• Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.

  2018influential citation
• Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium

  2018cites this paper
• Repeat length variations in polyglutamine disease-associated genes affect body mass index

  2018cites this paper
• Anti-Inflammatory Drug Use and Ovarian Cancer Risk by COX1/COX2 Expression and Infiltration of Tumor-Associated Macrophages

  2018cites this paper
• Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study

  2018cites this paper
• Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association Consortium

  2018cites this paper
• Androgen receptor gene CAG repeat polymorphism and ovarian cancer risk: A meta-analysis.

  2017cites this paper
• Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium

  2017cites this paper
• History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium

  2017cites this paper
• Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies

  2017cites this paper
• History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report

  2017cites this paper
• G 1733 A Polymorphism of the Androgen Receptor Gene and Recurrent Spontaneous Abortion in Saudi ’ s Women

  2017cites this paper
• Inhibition of tumor cell growth by adenine is mediated by apoptosis induction and cell cycle S phase arrest

  2017cites this paper
• History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium

  2017cites this paper
• Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk

  2016cites this paper
• Association of androgen receptor CAG repeat polymorphism and risk of epithelial ovarian cancer.

  2016cites this paper
• A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer

  2016cites this paper
• The role of the androgen receptor in ovarian cancer carcinogenesis and its clinical implications

  2016cites this paper
• Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium

  2016cites this paper
• Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.

  2016cites this paper
• Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium

  2016cites this paper
• The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies.

  2016cites this paper
• Endometriosis and ovarian cancer: potential benefits and harms of screening and risk-reducing surgery.

  2015cites this paper
• The androgen receptor cytosine-adenine-guanine repeat length contributes to the development of epithelial ovarian cancer

  2015cites this paper
• Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium

  2015influential citation
• Evaluation of hysterectomy as both exposure and outcome: Association with epithelial ovarian cancer and prediction of premenopausal hysterectomy with ovarian conservation

  2015cites this paper
• Title Obesity and survival among women with ovarian cancer : Results from the Ovarian Cancer Association Consortium Permalink

  2015influential citation
• Androgen receptor (CAG)n polymorphisms and breast cancer risk in a Han Chinese population.

  2015cites this paper
• Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.

  2014influential citation
• RETRACTED ARTICLE: The AIB1 gene polyglutamine repeat length polymorphism contributes to risk of epithelial ovarian cancer risk: a case–control study

  2014cites this paper
• Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis

  2014cites this paper
• Androgen receptor CAG repeats, non-random X chromosome inactivation, and loss of heterozygosity at Xq25 in relation to breast cancer risk

  2014cites this paper
• Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case–control studies

  2013cites this paper
• [Endometriosis as a risk factor for ovarian cancer].

  2013cites this paper
• La endometriosis como factor de riesgo para cáncer de ovario

  2013cites this paper
• Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium

  2013influential citation
• Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.

  2013cites this paper
• Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.

  2013cites this paper
• Base excision repair: contribution to tumorigenesis and target in anticancer treatment paradigms.

  2012cites this paper
• Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies

  2012cites this paper
• Analysis of 6 single-nucleotide polymorphisms in the androgen receptor gene in Chilean patients with primary spermatogenic failure.

  2012cites this paper
• Assessing Ovarian Cancer Risk When Considering Elective Oophorectomy at the Time of Hysterectomy

  2011cites this paper
• Revisiting the role of antiandrogen strategies in ovarian cancer.

  2011cites this paper
• Androgen Receptor Gene CAG Repeat Polymorphism and Breast Cancer Risk in Iranian Women: A Case‐Control Study

  2011cites this paper
• Genetic susceptibility to sporadic ovarian cancer: a systematic review.

  2011cites this paper
• A polymorphism in the GALNT 2 gene and ovarian cancer risk in four population based case-control studies

  2011cites this paper
• A polymorphism in the GALNT2 gene and ovarian cancer risk in four population based case-control studies.

  2010cites this paper
• Original Article A polymorphism in the GALNT2 gene and ovarian cancer risk in four population based case-control studies

  2010cites this paper
• Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer risk.

  2010cites this paper
• Pooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma risk

  2010cites this paper
• A MIS PADRES

  2010cites this paper
• Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations

  2009cites this paper
• Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome.

  2009cites this paper
• Polymorphic (CAG)n repeats in the androgen receptor gene: a risk marker for endometriosis and uterine leiomyomas.

  2009cites this paper
• Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.

  2009cites this paper
• Gynecological Aspects of Transgender Healthcare

  2009cites this paper
• Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer

  2009cites this paper
• Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies.

  2009cites this paper
• Gynecological Aspects of Transgender Healthcare

  2009cites this paper
• Individual differences in allocation of funds in the dictator game associated with length of the arginine vasopressin 1a receptor RS3 promoter region and correlation between RS3 length and hippocampal mRNA

  2008cites this paper
• Sex steroid-related candidate genes in psychiatric disorders.

  2008cites this paper
• Talc Use, Variants of the GSTM1, GSTT1, and NAT2 Genes, and Risk of Epithelial Ovarian Cancer

  2008cites this paper
• Androgens and epithelial ovarian cancer: What's the connection?

  2008cites this paper
• Evidence for association of the G1733A polymorphism of the androgen receptor gene with recurrent spontaneous abortions.

  2008cites this paper
• Polymorphisms of CYP17A1, CYP19, and androgen in Brazilian women with uterine leiomyomas

  2008cites this paper
• Androgen receptor gene haplotype is associated with male infertility.

  2008influential citation
• Trinucleotide repeats are prevalent among cancer-related genes.

  2008cites this paper
• Genetic Variation of the Androgen Receptor and Risk of Myocardial Infarction and Ischemic Stroke in Women

  2008cites this paper
• X chromosome studies and breast and ovarian carcinoma

  2007influential citation
• Shorter CAG repeat length in the AR gene is associated with poor outcome in head and neck cancer.

  2007cites this paper
• Phenotypic heterogeneity of mutations in androgen receptor gene.

  2007cites this paper
• Increased risk of breast cancer in women bearing a combination of large CAG and GGN repeats in the exon 1 of the androgen receptor gene.

  2007cites this paper
• Androgeeni retseptori, folliikuleid stimuleeriva hormooni retseptori ja inhibiini α-subühiku geenide polümorfismide seos idiopaatilise mehepoolse viljatusega

  2007cites this paper
• Increased risk of ovarian cancer in integrin beta3 Leu33Pro homozygotes.

  2005cites this paper